Johnson & Johnson Portfolio Stock Holdings

According to the SEC 13F filed on August 6, 2026, Johnson & Johnson disclosed 13 stock positions valued at approximately $798.65M as of quarter-end June 30, 2026. The largest holdings include PROTAGONIST THERAPEUTICS INC, NANOBIOTIX, and MEIRAGTX HLDGS PLC.

Report Period
June 30, 2026
No. of Stocks
13
Portfolio Value
$798.65M
Holdings by Sector
Johnson & Johnson Portfolio Holdings in Q2 2026
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
PROTAGONIST THERAPEUTICS INCPTGXHealthcare37.59%2,449,183--$300,220,852
NANOBIOTIXNBTXHealthcare26.55%5,623,816--$212,017,863
MEIRAGTX HLDGS PLCMGTXOther11.23%6,641,064--$89,720,775
RAPPORT THERAPEUTICS INCRAPPHealthcare9.31%1,784,517--$74,360,823
CONTINEUM THERAPEUTICS INCCTNMHealthcare4.06%1,979,173--$32,438,645
LEGEND BIOTECH CORPLEGNHealthcare2.95%814,586--$23,525,244
CVRX INCCVRXHealthcare2.59%4,024,861--$20,687,786
XENCOR INCXNCRHealthcare1.51%748,062--$12,043,798
CEREBRAS SYSTEMS INCCBRSOther1.48%53,586+53,586+100.00%$11,842,506
FATE THERAPEUTICS INCFATEHealthcare1.14%3,379,064--$9,123,473
PROCEPT BIOROBOTICS CORPPRCTHealthcare1.01%357,939--$8,082,263
NEUMORA THERAPEUTICS INC.NMRAHealthcare0.39%1,849,445--$3,144,057
STANDARD BIOTOOLS INCLABHealthcare0.03%311,967--$256,655
Showing 13 of 13 holdings in the latest reporting period.